cumberlandpharma.com - CPIX Company profit before taxes, interest and amortization
Cumberland Pharmaceuticals operates in the B2B sector, supplying medications for gastroenterologists and intensive care units. Ownership of rare emergency antidotes ensures business stability. The EBITDA metric demonstrates cash flow before taxes, and currently the value of 0.00 determines the current profit level. Local capacities in the US and the humanitarian status of medicine minimize external political risks.
Cumberland Pharmaceuticals Inc. (CPIX) - metric breakdowns and financial figures
- market value and analyst target forecast:
- issuer market value details:
- issuer book value statistics:
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio Cumberland Pharmaceuticals|CPIX - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Cumberland Pharmaceuticals Inc|CPIX - Company Total Debt|Debts to Book Capitalization Cumberland Pharmaceuticals|CPIX - Company Long-Term Debt|Company Current Liabilities Cumberland Pharmaceuticals|Quick Liquidity cumberlandpharma.com
- earnings and market ratios statistics:
CPIX - Net Profit|Expected Net Profit Cumberland Pharmaceuticals|CPIX - Price to Earnings Ratio|Future Price to Earnings Multiple cumberlandpharma.com|CPIX - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Cumberland Pharmaceuticals|CPIX - Operating profit EBITDA|Net earnings per share (EPS TTM) Cumberland Pharmaceuticals|CPIX - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last 12 months cumberlandpharma.com|CPIX - Earnings growth in current year|Projected earnings per share growth rate for next year Cumberland Pharmaceuticals
Fundamental company valuation:CPIX (Cumberland Corp)
Absolute operating profit in cash terms measures the actual cash flow from core operations, stripped of accounting adjustments and subjective valuations. Analyzing this metric allows investors to verify the actual efficiency of the business, while tracking EBITDA confirms the ability of Cumberland Pharmaceuticals (CPIX) to monetize niche drugs through US public and private insurance systems.
Competitors of Cumberland Pharmaceuticals (CPIX)
Haleon Corp (HLN) - Profit before interest, taxes and amortization|KVUE: Operating profit before deduction of amortization|veronapharma.com - Company profit before taxes, interest and amortization|MENS: Operating profit EBITDA|Ligand Pharmaceuticals Incorporated - Income before deduction of interest, taxes and amortization|AMRX (Amneal Pharmaceuticals Inc) - Operating profit EBITDA|Profit before interest, taxes and amortization Perrigo Corp PRGO|Profit before payment of interest, taxes and amortization Alvotech (ALVO)|LQDA (liquidia.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA GLPG (Galapagos)|ANIP - Operating profit before deduction of amortization|MNKD: Operating profit before deduction of amortization|AMPH - Operating profit EBITDA|Pacira BioSciences (PCRX) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization ars-pharma.com|TBPH (Theravance Biopharma, Inc.) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization AQST|Operating profit EBITDA SCPH|TECX - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Tonix Pharmaceuticals TNXP|Income before deduction of interest, taxes and amortization SXTC|EPRX - Profit before payment of interest, taxes and amortization|BHST: Profit before payment of interest, taxes and amortization|EXOZ: Operating profit EBITDA|Oramed Pharmaceuticals Inc. (ORMP) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization Entera Bio Ltd|Operating profit before amortization HYFT (ipatherapeutics.com)|Operating profit EBITDA ABVC|Quantum BioPharma Ltd. - Operating profit before amortization|FibroGen Corp - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization TELO|RANI - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization SNYR|RLYB: Operating profit EBITDA|Lexaria Bioscience Corp. - Income before deduction of interest, taxes and amortization|PULM (Pulmatrix Corp) - Operating profit EBITDA|Operating profit EBITDA Pheton|Profit before payment of interest, taxes and amortization Aptorum Group Limited (APM)|LYRA (lyratherapeutics.com) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Impact BioMedical IBO|TNFA - Operating profit before deduction of amortization|cbdMD Corp - Operating profit EBITDA|PRFX - Operating profit EBITDA|CYTO: Operating profit EBITDA|Operating profit before deduction of amortization lipella.com|OPTN (OptiNose) - Operating profit EBITDA|Profit before interest, taxes and amortization Pieris Pharmaceuticals Inc PIRS|Operating profit before deduction of amortization PROC (Procaps Group SA)|Operating profit EBITDA Petros Pharma (PTPI)|Qilian International - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization SLRN (acelyrin.com)|TFF Pharmaceuticals, Inc. - Operating profit EBITDA
